Orchard Announces Multiple Presentations at 2022 ESGCT Annual Congress Showing the Potential of HSC Gene Therapy in Several Therapeutic Areas

October 10, 2022

https://www.globenewswire.com/news-release/2022/10/10/2530876/0/en/Orchard-Announces-Multiple-Presentations-at-2022-ESGCT-Annual-Congress-Showing-the-Potential-of-HSC-Gene-Therapy-in-Several-Therapeutic-Areas.html

Clinical and pre-clinical data from across the company’s portfolio will be featured in four oral and six poster presentations

Co-founder and Chief Executive Officer Bobby Gaspar to give invited talk exploring the curative potential of HSC gene therapy when coupled with widespread newborn screening

Read more at globenewswire.com

Related news for (ORTX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.